fluorouracil has been researched along with pi103 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akram, M; Balasubramanian, I; Bhattacharya, B; Koh, KX; Soong, R; Tam, KK; Yee, MQ | 1 |
| Beloueche-Babari, M; Bhattacharya, B; Kamal Mustapa, N; Koh, KX; Loh, J; Low, SH; Soh, C; Soong, R | 1 |
2 other study(ies) available for fluorouracil and pi103
| Article | Year |
|---|---|
Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-fluorouracil in PIK3CA mutant gastric cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Drug Synergism; Female; Fluorouracil; Furans; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Pyrimidines; Stomach Neoplasms; TOR Serine-Threonine Kinases; Transcription Factors; Xenograft Model Antitumor Assays | 2012 |
Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype.
Topics: Antineoplastic Agents; Autophagy; Carboplatin; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Furans; Glucose; Glycolysis; Humans; Hypoglycemia; Morpholines; Phenotype; Phosphatidylinositol 3-Kinases; Pyridines; Pyrimidines; Signal Transduction; Stomach Neoplasms; TOR Serine-Threonine Kinases | 2014 |